- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement ; volume:6 ; number:2 ; year:2020 ; pages:65-73
Kidney diseases ; 6, Heft 2 (2020), 65-73
- Urheber
- DOI
-
10.1159/000504850
- URN
-
urn:nbn:de:101:1-2020032523175469532179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Zuo-Lin
- Tu, Yan
- Liu, Bi-Cheng
Ähnliche Objekte (12)
Management guidelines for the treatment of renal anemia
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Cardio renal anemia syndrome
Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
A new insight into the treatment of renal anemia with HIF stabilizer
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges
Compassionate use of roxadustat for treatment of refractory renal anemia in an infant
Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia
Treatment of renal anemia with recombinant human erythropoietin : internat. workshop, Wolfenbüttel, November 22 - 24, 1987
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Renal artery embolization before radical nephrectomy for complex renal tumour: which are the true advantages?
Management guidelines for the treatment of renal anemia
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Cardio renal anemia syndrome
Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
A new insight into the treatment of renal anemia with HIF stabilizer
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges
Compassionate use of roxadustat for treatment of refractory renal anemia in an infant
Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia
Treatment of renal anemia with recombinant human erythropoietin : internat. workshop, Wolfenbüttel, November 22 - 24, 1987
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
Renal artery embolization before radical nephrectomy for complex renal tumour: which are the true advantages?
Management guidelines for the treatment of renal anemia
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Cardio renal anemia syndrome
Achievement of renal anemia KDIGO targets by two different clinical strategies – a European hemodialysis multicenter analysis
A new insight into the treatment of renal anemia with HIF stabilizer
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges
Compassionate use of roxadustat for treatment of refractory renal anemia in an infant
Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia
Treatment of renal anemia with recombinant human erythropoietin : internat. workshop, Wolfenbüttel, November 22 - 24, 1987
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis